Jon Kirk Plummer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 190 County Road 45650, Blossom, TX 75416 Phone: 903-784-4627 |
News Archive
Twenty-four month findings from IMPROVE HF, (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting), funded by Medtronic, Inc., demonstrated that clinics using the process improvement program increased adherence to evidence-based, guideline-recommended care by 82 and 62 percent, respectively, for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) use, and 80 percent for aldosterone antagonist use, all relative to baseline results.
Australian researchers have called for additional services for survivors of intimate partner violence - warning those who have these experiences are more vulnerable to elder abuse.
Nurses on the bariatric surgery care team at a Connecticut hospital were having difficulty keeping track of patients' fluid intake after hospital admission.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
› Verified 5 days ago